GENEVA, Sept. 18 -- B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD. filed a patent application (IL2026/050191) for “A SINGLE-DOMAIN ANTIBODY FOR TARGETING B-CELL MATURATION ANTIGEN (BCMA)”. With publication no. WO/2026/185844, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 16/28
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....